Comparison between Apibee Natural Product IPO and Himalaya Nutravedics IPO.
Apibee Natural Product IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Himalaya Nutravedics IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of Apibee Natural Product IPO is up to ₹0.00 Cr whereas the issue size of the Himalaya Nutravedics IPO is up to ₹0.00 Cr. The final issue price of Apibee Natural Product IPO is and of Himalaya Nutravedics IPO is .
| Apibee Natural Product IPO | Himalaya Nutravedics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 35,71,200 shares | 25,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,71,200 shares | 25,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Apibee Natural Product IPO opens on , while Himalaya Nutravedics IPO opens on . The closing date of Apibee Natural Product IPO and Himalaya Nutravedics IPO is , and , respectively.
Apibee Natural Product IPO P/E ratio is , as compared to Himalaya Nutravedics IPO P/E ratio of .
| Apibee Natural Product IPO | Himalaya Nutravedics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)Himalaya Nutravedics India Ltd.'s revenue increased by 105% and profit after tax (PAT) rose by 231% between the financial year ending with March 31, 2026 and March 31, 2025.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.36 | 95.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 69.46 | 63.87 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 29.57 | 36.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.40 | 0.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 69.46 | 45.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Apibee Natural Product IPO Retail Individual Investors (RII) are offered 0 shares while in Himalaya Nutravedics IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Apibee Natural Product IPO and 0 shares in Himalaya Nutravedics IPO.
| Apibee Natural Product IPO | Himalaya Nutravedics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 2,14,800 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Apibee Natural Product IPO subscribed in total, whereas Himalaya Nutravedics IPO subscribed .
